Profound Analysis of Equity Shares ~ Zydus Cadila

PM Narendra Modi reviews vaccine development at Zydus Cadila facility in Gujarat

Wearing a PPE kit, Modi reviewed the vaccine development process at the Zydus Cadila research center in Changodar industrial area, over 20 km from Ahmedabad.

PTI NOV 28, 2020 / 11:35 AM IST

Zydus Cadila said it will apply for Phase 3 clinical trials of its experimental COVID-19 vaccine in December and expects to launch it by March 2021

The share price jumped over 3 percent in the morning session on November 27 after Zydus Cadila said it will apply for Phase 3 clinical trials of its experimental COVID-19 vaccine in December and expects to launch it by March 2021.

"If all goes well, the company expects to introduce the vaccine by March next year," a source told The Economic Times.

Day-to-day Graph

One Day gain of the share is 2.82%

Open at 450.80 and an all-time high of 463.80 since the beginning

After the breakdown of Covid-19 company is continuously focusing on vaccine

The company already passed phase 3 of the trial and it is ready for use by March 2021.

Though the share price is rising with all this information, Today's sell is more than buy which is not so good sign

Total Sell is 11.9k that is 65% and total but is just 6329k that is 35%

The overall growth of the company since the pandemic is huge.

Looks like the Best time to invest is now for this company.

LongTerm Tip :

Set a price limit of 520 and stop loss of 430